MedTrace Logo

Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy

NCT04075708 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1427

Last updated 2020-10-19

No results posted yet for this study

Summary

The aim of this study is to make it easier to predict late-onset preeclampsia at 11-14 weeks of pregnancy. This will be done by measuring certain proteins in the mother's blood together with obtaining the mother's medical history, ultrasound of the mother's blood supply to the uterus, and her blood pressure.

All expectant mothers who meet the inclusion criteria will be invited to participate in the study, and those that agree will have the above mentioned factors measured at their first trimester scan appointment. The data will be registered in an online database, and the blood samples will be saved in a biobank at the hospital.

When the women have then given birth around six months later, the data will be analyzed, and whether or not the individual woman ended up developing preeclampsia will be found out from her medical records. It will then be possible to see if blood samples, medical history, blood supply to the uterus, and/or blood pressure are connected to development of preeclampsia.

Conditions

Sponsors & Collaborators

  • University of Southern Denmark

    lead OTHER

Principal Investigators

  • Lene Sperling, M.D., PhD · Odense University Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-13
Primary Completion
2020-09-01
Completion
2020-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04075708 on ClinicalTrials.gov